Literature DB >> 20152562

Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions.

Oussama Wazni1, Laurence M Epstein, Roger G Carrillo, Charles Love, Stuart W Adler, David W Riggio, Shahzad S Karim, Jamil Bashir, Arnold J Greenspon, John P DiMarco, Joshua M Cooper, John R Onufer, Kenneth A Ellenbogen, Stephen P Kutalek, Sherri Dentry-Mabry, Carolyn M Ervin, Bruce L Wilkoff.   

Abstract

OBJECTIVES: This study sought to examine the safety and efficacy of laser-assisted lead extraction and the indications, outcomes, and risk factors in a large series of consecutive patients.
BACKGROUND: The need for lead extraction has been increasing in direct relationship to the increased numbers of cardiovascular implantable electronic devices.
METHODS: Consecutive patients undergoing transvenous laser-assisted lead extraction at 13 centers were included.
RESULTS: Between January 2004 and December 2007, 1,449 consecutive patients underwent laser-assisted lead extraction of 2,405 leads (20 to 270 procedures/site). Median implantation duration was 82.1 months (0.4 to 356.8 months). Leads were completely removed 96.5% of the time, with a 97.7% clinical success rate whereby clinical goals associated with the indication for lead removal were achieved. Failure to achieve clinical success was associated with body mass index <25 kg/m(2) and low extraction volume centers. Procedural failure was higher in leads implanted for >10 years and when performed in low volume centers. Major adverse events in 20 patients were directly related to the procedure (1.4%) including 4 deaths (0.28%). Major adverse effects were associated with patients with a body mass index <25 kg/m(2). Overall all-cause in-hospital mortality was 1.86%; 4.3% when associated with endocarditis, 7.9% when associated with endocarditis and diabetes, and 12.4% when associated with endocarditis and creatinine > or =2.0. Indicators of all-cause in-hospital mortality were pocket infections, device-related endocarditis, diabetes, and creatinine > or =2.0.
CONCLUSIONS: Lead extraction employing laser sheaths is highly successful with a low procedural complication rate. Total mortality is substantially increased with pocket infections or device-related endocarditis, particularly in the setting of diabetes, renal insufficiency, or body mass index <25 kg/m(2). Centers with smaller case volumes tended to have a lower rate of successful extraction. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20152562     DOI: 10.1016/j.jacc.2009.08.070

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  89 in total

1.  The effect of device advisories on implantable cardioverter-defibrillator therapy.

Authors:  Mitesh S Amin; Kenneth A Ellenbogen
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

Review 2.  [Percutaneous lead extraction. Complications and their management].

Authors:  Heiko Burger
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-12

3.  Successful extraction of right ventricular lead remnants using the FlexCath® steerable sheath.

Authors:  Tanyanan Tanawuttiwat; Alan Cheng; John Rickard; Grant V Chow; Christopher M Sciortino; Jeffrey Brinker
Journal:  J Interv Card Electrophysiol       Date:  2015-09-03       Impact factor: 1.900

Review 4.  Considerations for cardiac device lead extraction.

Authors:  Oussama Wazni; Bruce L Wilkoff
Journal:  Nat Rev Cardiol       Date:  2016-01-29       Impact factor: 32.419

5.  Use and Abuse of Internal Cardioverter Defibrillators for Primary Prevention.

Authors:  Joshua R Silverstein; Demosthenes G Katritsis; Mark E Josephson
Journal:  Arrhythm Electrophysiol Rev       Date:  2012-09

6.  Re-evaluation of transvenous lead extraction with modified standard technique: a prospective study in 229 patients.

Authors:  Xian-Ming Chu; Xue-Bin Li; Ping Zhang; Long Wang; Ding Li; Jiang-Bo Duan; Bing Li; Ji-Hong Guo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10-20

Review 7.  Infections associated with cardiac implantable electronic devices are misunderstood.

Authors:  Bruce L Wilkoff
Journal:  Tex Heart Inst J       Date:  2011

Review 8.  Transvenous Lead Extractions: Current Approaches and Future Trends.

Authors:  Adryan A Perez; Frank W Woo; Darren C Tsang; Roger G Carrillo
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

9.  Update on indications, techniques, and complications of cardiac implantable device lead extraction.

Authors:  Charles J Love
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-10

10.  Implantable cardioverter defibrillator lead-related methicillin resistant Staphylococcus aureus endocarditis: Importance of heightened awareness.

Authors:  Obiora F Anusionwu; Cheri Smith; Alan Cheng
Journal:  World J Cardiol       Date:  2012-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.